Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 3/20 | 0.34 |
| ▸ | MME | P08473 | 3/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.31 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.31 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.31 |
| ▸ | LAP3 | P28838 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | GGH | Q92820 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27560755 | 0.94 | FOLH1 (0.32) | OR51E2TGFBR1MMEFOLH1RIMKLA | |
| SCHEMBL2134050 | 0.81 | TGFBR1 (0.45) | OR51E2TGFBR1MMEFOLH1RIMKLA | |
| SCHEMBL27091944 | 0.81 | TGFBR1 (0.45) | OR51E2TGFBR1MMEFOLH1RIMKLA | |
| SCHEMBL8471952 | 0.80 | SLC1A1 (0.45) | TGFBR1MMEFOLH1RIMKLANAALAD2 | |
| SCHEMBL1418301 | 0.79 | TGFBR1 (0.43) | OR51E2TGFBR1MMEFOLH1RIMKLA | |
| SCHEMBL8934471 | 0.78 | FOLH1 (0.39) | MMEFOLH1NAALAD2LAP3LMNA | |
| SCHEMBL629640 | 0.77 | ECE1 (0.40) | OR51E2TGFBR1MMELAP3CA2 | |
| SCHEMBL24119241 | 0.75 | ALDH1A1 (0.55) | MMEFOLH1LAP3LMNAALDH1A1 | |
| SCHEMBL8358625 | 0.73 | FOLH1 (0.43) | FOLH1RIMKLANAALAD2LMNAGGH | |
| SCHEMBL8585891 | 0.73 | FOLH1 (0.36) | MMEFOLH1NAALAD2LAP3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1074 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026102602-A1 | COMPOSITION FOR DYEING KERATIN FIBERS | L'OREAL (FR) | 2026-05-21 | — | — | WO | claimed |
| CN-119968190-A | Composition for caring keratin materials and dressing film containing the same | 莱雅公司 | 2025-05-09 | — | — | CN | claimed |
| US-20250025400-A1 | COSMETIC COMPOSITION FOR CARING FOR THE SKIN | L'OREAL (FR) | 2025-01-23 | — | — | US | claimed |
| EP-4456866-A1 | COSMETIC COMPOSITION FOR CARING FOR THE SKIN | L'OREAL (FR) | 2024-11-06 | — | — | EP | claimed |
| US-20240269053-A1 | COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS | L'OREAL (FR) | 2024-08-15 | — | — | US | claimed |
| CN-118475337-A | Cosmetic composition for caring skin | 莱雅公司 | 2024-08-09 | — | — | CN | claimed |
| CN-118302148-A | Composition for cleaning and conditioning hair | 莱雅公司 | 2024-07-05 | — | — | CN | claimed |
| EP-4358926-A1 | COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS | L'OREAL (FR) | 2024-05-01 | — | — | EP | claimed |
| WO-2024065609-A1 | COMPOSITION FOR CARING FOR KERATIN MATERIALS AND MASK CONTAINING THE SAME | L'OREAL (FR) | 2024-04-04 | — | — | WO | claimed |
| CN-117500476-A | Composition for cleaning and/or removing makeup from keratin materials | 莱雅公司 | 2024-02-02 | — | — | CN | claimed |
| WO-2022266943-A1 | COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS | L'OREAL (FR) | 2022-12-29 | — | — | WO | claimed |
| WO-2022150949-A1 | BIPHASE COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS | L'OREAL (FR) | 2022-07-21 | — | — | WO | claimed |
| US-20110081307-A1 | KIT COMPRISING AN ALGINATE AND A COMPLEXING AGENT IN THE FORM OF A WATER-SOLUBLE SALT | L'OREAL (FR) | 2011-04-07 | — | — | US | claimed |
| US-20100316577-A1 | KIT COMPRISING AN ALGINATE AND A COMPLEXING AGENT IN THE FORM OF A WATER-INSOLUBLE SALT | L'OREAL | 2010-12-16 | — | — | US | claimed |
| CN-101903012-A | The cosmetic container that comprises the chelating agent of alginate and water-insoluble salt form | OREAL | 2010-12-01 | — | — | CN | claimed |
| CN-101903007-A | The cosmetic container that comprises the chelating agent of alginate and water soluble salt form | OREAL | 2010-12-01 | — | — | CN | claimed |
| EP-2234589-A2 | KIT COMPRISING AN ALGINATE AND A COMPLEXING AGENT IN THE FORM OF A WATER-SOLUBLE SALT | L'Oréal (FR) | 2010-10-06 | — | — | EP | claimed |
| EP-2234590-A2 | KIT COMPRISING AN ALGINATE AND A COMPLEXING AGENT IN THE FORM OF A WATER-INSOLUBLE SALT | L'Oréal (FR) | 2010-10-06 | — | — | EP | claimed |
| WO-2009080628-A2 | KIT COMPRISING AN ALGINATE AND A COMPLEXING AGENT IN THE FORM OF A WATER-SOLUBLE SALT | L'OREAL (FR) | 2009-07-02 | — | — | WO | claimed |
| WO-2009080627-A2 | KIT COMPRISING AN ALGINATE AND A COMPLEXING AGENT IN THE FORM OF A WATER-INSOLUBLE SALT | L'OREAL (FR) | 2009-07-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250025400-A1 | COSMETIC COMPOSITION FOR CARING FOR THE SKIN | CUTA, DSG1, TYR | OR51E2 1520/4885TGFBR1 4114/4885MME 1190/4885 |
| US-20240269053-A1 | COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS | KRT18, CUTA, S100A4 | OR51E2 2856/4885TGFBR1 3353/4885MME 1381/4885 |
| US-20110081307-A1 | KIT COMPRISING AN ALGINATE AND A COMPLEXING AGENT IN THE FORM OF A WATER-SOLUBLE SALT | KIT, PKD1, MASTL | OR51E2 2078/4885TGFBR1 1828/4885MME 4352/4885 |
| US-20100316577-A1 | KIT COMPRISING AN ALGINATE AND A COMPLEXING AGENT IN THE FORM OF A WATER-INSOLUBLE SALT | KIT, MASTL, PKD1 | OR51E2 2478/4885TGFBR1 2379/4885MME 4326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.